Cited by 15Down syndrome and intellectual disability researchAlzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Developmental changes of apolipoprotein E immunoreactivity in Down syndrome brains

Arai, Yasuhiro, Mizuguchi, Masashi, Ikeda, Kazuhiko, Takashima, Sachio·1995·Developmental Brain Research

Abstract

The temporal profile of apolipoprotein-E (apo-E) expression was investigated immunohistochemically in the brains of Down syndrome patients and of normal controls. The number of apo-E immunoreactive astrocytes in the frontal cortex was larger in Down syndrome patients than in controls from 7 months to 24 years of age. It suggests that apo-E producing astrocytes in the early phase of pathological process lead to presenile dementia in Down syndrome patients. In contrast, the number in the white matter was smaller in Down syndrome patients from 28 gestational weeks to 5 years. Apo-E immunoreactive senile plaques were noted in Down syndrome brains from the age of 25 years, while APP immunoreactivity was first noted in senile plaques at the age of 32 years.

Integrity signals

Registry

Crossref · 10.1016/0165-3806(95)00066-m

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cited by

Sorted by citations

Authors
Arai, Y., Mizuguchi, M., Ikeda, K., & Takashima, S.
Affiliations
  • National Center of Neurology and Psychiatry (JP)
  • Tokyo Institute of Psychiatry (JP)
Venue
Developmental Brain Research
Publisher
Elsevier BV
Published
1995-07
Volume
87
Issue
2
Pages
228-232
ISSN
0165-3806 (ISSN-L)
OpenAlex
W1997879125
Cited by
15
References
0
Citations by year
2025: 2 · 2022: 3 · 2020: 1 · 2019: 1 · 2018: 1
FWCI
1.99
Type
journal article
Language
en
Open access
closed
Locations
  • Developmental Brain Research (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Down syndrome and intellectual disability research
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords
apolipoprotein E, Down syndrome, astrocytes, frontal cortex, white matter, amyloid plaques, amyloid precursor protein, early-onset dementia, brain development, immunoreactivity
MeSH terms
Adolescent, Adult, Aging, Apolipoproteins E, Astrocytes, Brain, Child, Child, Preschool, Down Syndrome, Embryonic and Fetal Development, Fetus, Humans, Immunohistochemistry, Infant, Infant, Newborn, Middle Aged, Tissue Distribution

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review